Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456.
作者信息
Hickson LaTonya J, Langhi Prata Larissa G P, Bobart Shane A, Evans Tamara K, Giorgadze Nino, Hashmi Shahrukh K, Herrmann Sandra M, Jensen Michael D, Jia Qingyi, Jordan Kyra L, Kellogg Todd A, Khosla Sundeep, Koerber Daniel M, Lagnado Anthony B, Lawson Donna K, LeBrasseur Nathan K, Lerman Lilach O, McDonald Kathleen M, McKenzie Travis J, Passos João F, Pignolo Robert J, Pirtskhalava Tamar, Saadiq Ishran M, Schaefer Kalli K, Textor Stephen C, Victorelli Stella G, Volkman Tammie L, Xue Ailing, Wentworth Mark A, Wissler Gerdes Erin O, Allison David B, Dickinson Stephanie L, Ejima Keisuke, Atkinson Elizabeth J, Lenburg Marc, Zhu Yi, Tchkonia Tamara, Kirkland James L
机构信息
Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States.
出版信息
EBioMedicine. 2020 Feb;52:102595. doi: 10.1016/j.ebiom.2019.12.004. Epub 2020 Jan 23.
Zotero 插件